IFNG and viral hepatitis: Therefore, we could not exclude the possibility that targeting the PD-1 pathway could boost recall IFNγ responses of HIV-uninfected persons, particularly those with factors that are known to induce T cell exhaustion, such as viral hepatitis [35] or aging [27].